Cargando…
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
BACKGROUND: The aim of the study was to estimate the minimally important difference (MID) for interpreting group-level change over time, both within a group and between groups, for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) sc...
Autores principales: | Gamper, Eva M., Musoro, Jammbe Z., Coens, Corneel, Stelmes, Jean-Jacques, Falato, Claudette, Groenvold, Mogens, Velikova, Galina, Cocks, Kim, Flechtner, Hans-Henning, King, Madeleine T., Bottomley, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496068/ https://www.ncbi.nlm.nih.gov/pubmed/34620124 http://dx.doi.org/10.1186/s12885-021-08609-7 |
Ejemplares similares
-
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
por: Musoro, Jammbe Z, et al.
Publicado: (2019) -
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021) -
Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
por: Musoro, Zebedee Jammbe, et al.
Publicado: (2018) -
Comparing higher order models for the EORTC QLQ-C30
por: Gundy, Chad M., et al.
Publicado: (2011) -
Investigating the response scale of the EORTC QLQ-C30 in German cancer patients and a population survey
por: Koller, Michael, et al.
Publicado: (2021)